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Abstract
It has become commonplace for Randomized Controlled Trials (RCTs) to be analyzed according
to Intention-to-Treat (ITT) principles in which data from all subjects are used regardless of the
subjects' adherence to protocol. While ITT analyses can provide useful information in some cases,
they do not answer the question that motivates many RCTs, namely, whether the treatments differ
in efficacy. ITT tends to reduce information by combining two questions, whether the intervention
is effective and whether, as implemented, it has good compliance. Because these questions may be
separate there is a risk of misuse. Two examples are presented that demonstrate this potential for
abuse: a study on the effectiveness of vitamin E in reducing cardiovascular risk and comparisons of
low fat and low carbohydrate diets. In the first case, a treatment that is demonstrably effective is
described as without merit. In the second, ITT describes as the same, two diets that actually have
different outcomes. These misuses of ITT are not atypical and are not technical problems in
statistics but have real consequences for scientific principles and health recommendations. ITT
analyses may answer the question of what happens when treatments are recommended but are
inappropriate where separate information on adherence and performance is available. It is
proposed that results of RCTs, or any experimental study, be reported, not in terms of the analyses
that were performed, but rather in terms of the questions that the analyses can answer properly.
Background
Randomized Controlled Trials (RCT) are typically per-
formed to compare the efficacy of two or more treatments.
One problem that has vexed investigators for as long as
there have been comparative trials is that experimental
subjects don't always follow instructions; in the Women's
Health Intiative (WHI), for example, after 6 years, only
14% of the women randomized to cutting fat to 20% of
calories were meeting their goal [1,2]. More important, in
some studies, subjects drop out altogether. In the latter
case, at least, it seems reasonable that data on such non-
participants should not be included in the final analysis of
the data.
Recently, however, a statistical concept, Intention-to-Treat
(ITT) analysis, has appeared. In ITT, the data from all sub-
jects who are randomized to treatment are analyzed
regardless of whether subjects followed the protocol or
not ("analyze as randomized"). At first hearing, the idea
of ITT is counter-intuitive if not completely irrational –
why would you include in your data, people who are not
in the experiment? – suggesting that a substantial burden
of proof rests with those who want to employ it. No such
obligation is usually met and, particularly in nutrition
studies, such as comparisons of isocaloric weight loss
diets, ITT is frequently used without justification. ITT
analyses are typically reported in a way that implies that
they have the final say on efficacy and it is even argued
that, once assigned to an experimental group, all data must
be included in the analysis even if subjects do not comply
with the protocol [3]. Dallal has described the history suc-
cinctly and summarized the arguments, pro and con in an
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engaging manner although ultimately coming out gener-
ally against the practice [4]. Not surprisingly, there is a
good deal of controversy on this subject and because an
ITT analysis can draw the exact opposite conclusion to a
traditional one, the potential for confusion for the public
and scientific researchers alike is great.
What is the question?
"Unfortunately, people generally ignore the connec-
tions between the formal notions of statistics and the
informal understandings and stories from which they
grow. They consider numbers as coming from a differ-
ent realm than narratives and not as distillations, com-
plements or summaries of them. People often cite
statistics in bald form, without the supporting story
and context needed to give them meaning."
- John Allen Paulos, Once Upon a Number. The Hidden
Mathematical Logic of Stories (ref. [5]), p. 12
Both sides of the ITT controversy have strong opinions
and it is not clear how the dialogue can proceed. Here it is
suggested that, in any analysis of scientific data, attention
be paid to precisely what question is being asked and,
regardless of labels, results be reported as answers to those
questions. Thus, in a simple experiment in which the effi-
cacy of a dietary supplement is being studied, one sensibly
wants to answer the question "What happens if you take
the supplement?" In other words, one is generally inter-
ested in the efficacy of the supplement. Adherence,
because it may depend on the particular implementation
and the behavior of the subject, is a separate question. In
a more complicated experiment such as a weight loss diet
comparison, a slightly different question is "can people
stay on one or another diet?" ITT, because it is really ask-
ing the question "What happens if you are assigned to a
particular diet?" is collapsing the two questions of adher-
ence and efficacy into a single question. Reducing the two
questions to a single one limits the information that is
available. If ITT is used, it is important to be precise about
what question is being asked. Of course, many treatments
are inherently inconvenient and have unavoidable side
effects, causing subjects to become non-adherent when
benefits are uncertain or not immediately felt, but this
cannot be assumed to always be the case. Whatever the
general value of ITT, it is the confusion over what question
has been asked that leads to widespread misuse.
The major point of this commentary is that if ITT is used,
it must be clearly stated that it it is taking assignment to a
protocol as the independent variable, that is, it is asking
the question "what is the effect of being assigned to a par-
ticular group?"
In this commentary two cases are considered where inap-
propriate use of ITT can compromise scientific under-
standing and clinical recommendations: the effectiveness
of use of vitamin E as a dietary supplement and the rela-
tive efficacy of low carbohydrate and low fat diets. It is
argued that common sense suggests that the wrong ques-
tions were asked, or, when correctly stated, misinterpreted
as a consequence of use of ITT. Although restricted to die-
tary comparisons, the ideas are generalizable, and an
example is given of choice of therapy in coronary heart
disease.
The effect of vitamin E supplementation
A clear cut case of incorrect use of ITT is a recent report on
the value of antioxidant supplements [6]. The Abstract of
the paper concluded that "there were no overall effects of
ascorbic acid, vitamin E, or beta carotene on cardiovascu-
lar events among women at high risk for CVD." The study,
however, provided an ITT analysis and on the fourth page
of the paper, it turns out that removing subjects due to
"noncompliance led to a significant 13% reduction in the
combined end point of CVD morbidity and mortal-
ity...with a 22% reduction in MI ..., a 27% reduction in
stroke .... a 23% reduction in the combination of MI,
stroke, or CVD death (RR (risk ratio), 0.77; 95% CI, 0.64–
0.92 [P = .005])." The media universally reported the con-
clusion from the Abstract, namely that there was no effect
of vitamin E. This conclusion is incorrect if precise lan-
guage is used. No effect was the answer to the question
about the outcome of the assignments. It is reasonable
that the effect of the vitamins means the effect of taking
the vitamin and the data do show a significant effect.
From the standpoint of public health and preventive med-
icine, it is hard to see that ITT was the right analysis.
"The same at one year"
A more subtle problem of asking the right question is the
study of macronutrient composition of diets. The ques-
tion is of current interest in that the American Diabetes
Association (ADA), long an opponent of the use of low
carbohydrate diets (< 130 g/day), for the first time in
2008, gave weak endorsement to such diets for weight loss
[7]. While the change in position was ascribed to evolving
research, the data referenced are two studies from 2003
and 2004 comparing low-carbohydrate and conventional
diets. The studies of Stern, et al. [8] and of Foster, et al. [9]
are widely cited as showing that weight loss is better on a
low-carbohydrate diet at 6 months but is the same as that
for a low fat diet at 1 year and this is the interpretation
accepted by the ADA. It has, however, been pointed out
that because the low carb diet allowed re-introduction of
carbohydrate as the experiment proceeded, the diets
became similar at one year and that the implication was
that increased carbohydrate reduced effectiveness [10,11].
In any case, the idea that low-fat and low-carbohydrate
diets give the same results at one year persists and has
been quoted numerous times in the literature. Analysis of
the data, however, suggests that it is not correct.Nutrition & Metabolism 2009, 6:1 http://www.nutritionandmetabolism.com/content/6/1/1
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Stern, et al. [8] are apparently up front about the study
and report in their Abstract: "Participants received coun-
seling to either restrict carbohydrate intake... or to restrict
caloric intake." However, the Results in the Abstract are
reported: "By 1 year, mean (± SD) weight change for per-
sons on the low-carbohydrate diet was -5.1 ± 8.7 kg com-
pared with -3.1 ± 8.4 kg for persons on the conventional
diet. Differences between groups were not significant (-
1.9 kg [95% CI, -4.9 to 1.0 kg]; P = 0.20) .... Conclusion:
... Weight loss was similar between groups [at 1 year]...."
It is reasonable to assume, however, that persons
described as being on a diet have stayed on the diet, unless
it is clearly explained that they have not. Of course, com-
pliance to a long term diet may be very variable and, as in
the WHI [1], compliers may not all have had the same
nutritional intake. Nonetheless, it was possible to identify
those who had dropped out of the study and as part of the
analysis, the authors explain in the text ([8], p. 781) that
the data included the results for those who had dropped
out. When this sub-group is examined it was found that:
"Persons on the low-carbohydrate diet who dropped out
lost less weight than those who completed the study
(change, -0.2 ± 7.6 kg vs. -7.3 ± 8.3 kg, respectively; mean
difference, -7.1 kg [CI, -11.6 kg to -2.8 kg]; P = 0.003)."
This result is not surprising. Reflection on the statement,
however, suggests that the counter-intuitive idea that you
can be considered to be on a diet even if you drop out, has
been tacitly assumed.
The report continues, "In contrast, weight loss was not sig-
nificantly different for those on the conventional diet, whether
they dropped out or completed the study (change, -2.2 ± 9.5 kg
vs. -3.7 ± 7.7, respectively; mean difference, -1.5 kg [CI, -
5.7 kg to 2.7 kg]; P > 0.2). Nevertheless, the difference in
weight loss between the 2 diet groups for those who
dropped out of the study was not significant (P >0.2)."
(My italics).
The last two sentences mean that following a conven-
tional diet is indistinguishable from not following such a
diet. In other words, it doesn't matter whether you follow
a conventional diet or merely say you are going to follow
a conventional diet. To understand how this astounding
conclusion could be taken as evidence for the equality of
the two diets, one must consider what question is being
asked. Although, as noted above, the Abstract of Stern, et
al. begins circumspectly, the question shifts from the
effect of assignment to the diet to a question about the
diet itself. The inclusion of non-compliers is hidden, that
is, one does not know, until the body of the paper, that
some of the participants did not participate. The question
about assignment is different from the question of efficacy
unless it is assumed that adherence is an unalterable fea-
ture of the diet, rather than an effect of patient motivation
and experimental protocol. In practice, dieters rely on all
sorts of stimuli that may or may not be in the experimen-
tal protocols. A survey [12] of the Active Low-Carber
Forums [13], an on-line support group showed that there
was variable reliance on information from different
sources (e.g. popular books, TV or other media, manufac-
turers websites, online support forums) which can be sep-
arately controlled by different protocols. When the
question of adherence is separated from efficacy, the cor-
rect conclusion about the study of Stern, et al. is: Weight
loss was not similar between groups at 1 year (Table 1).
The study by Foster, et al. [9], which might be said to have
sparked the recent low carbohydrate revolution provided
similar data (Table 1): the difference between an ITT anal-
ysis and one based separately on performance of compli-
ers is clearly substantial. Whether the difference in results
is significant is not stated but it would be hard to say that
the diets are the same.
Thus, the conclusion that weight loss is the same at 1 year
on low-carbohydrate diets and conventional diets comes
from an ITT analysis and, as stated, is misleading. Because
dieters and practitioners reasonably want to know the
potential of a diet, it seems that authors must be very cir-
cumspect about describing results. The ITT analysis, again,
only answers the question about assignment to a diet in a
particular experimental setting, and does not address the
question as to which is the more effective diet if adhered
Table 1: Weight Loss in Diet Comparisons and the Effect of Analysis. Data from References [8,9].
Data for 12 months Weight Loss (kg)
With Drop-outs SD Only Study Subjects SD
Foster, et al. low carb 4.4 6.7 7.3 7.3
low fat 2.5 6.3 4.5 7.9
difference 1.9 2.8
Stern, et al. low carb 5.1 8.7 7.3 8.3
low fat 3.1 8.4 3.7 7.7
difference 23 . 6Nutrition & Metabolism 2009, 6:1 http://www.nutritionandmetabolism.com/content/6/1/1
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to. The fact that it is acknowledged that the substantially
greater improvement in plasma triglycerides on the low
carbohydrate diet compared to the low fat diets persisted
for one year should have been taken as a sign that it would
be surprising if the diets were the same [7,9].
Common sense argument against intention-to-
treat
Consider an experimental comparison of two diets in
which there is a discrete outcome, e.g. a threshold amount
of weight lost or remission of an identifiable symptom.
(The analysis is easily generalized to a continuous out-
come or to a drug trial.) Patients are randomly assigned to
two different diet, diet group A or diet group B and a target
of 5 kg weight loss is considered success. Assume that half
of the subjects in group A are able to stay on the diet and
half are not. The patients in this group who stayed on the
diet, however, are all able to lose the target 5 kg. Now in
group B, imagine that everybody is able to stay on the diet
but only half are able to lose the required amount of
weight. An ITT analysis shows no difference in the two
outcomes. With such data in hand should a physician
advise a patient: "well, the diets are pretty much the same.
It's largely up to you which you choose," or, looking at the
raw data (both compliance and success), should the rec-
ommendation be: "Diet A is much more effective than
diet B but people have trouble staying on it. If you can stay
on diet A it will be much better for you so I would encour-
age you to see if you could find a way to do so." Which
makes more sense?
Although diet trials are emphasized here, it is worthwhile
to apply the common sense test to a study where the
authors insist that ITT is appropriate. In the Coronary
Artery Bypass Surgery (CABS) trial, reproduced by Newell
[3], patients were assigned to Medicine or Surgery. The
actual modalities used and the outcomes are shown in
Table 2. Intention-to-treat analysis was, as described by
Newell, "used, correctly." A 7.8% mortality was found in
those allocated to medical treatment, and a 5.3% mortal-
ity for assignment to surgery. Values for those who actu-
ally received the assigned treatment were 8.4% for
medicine, and 4.1% for surgery. If, however, we look at
the outcomes of each modality as actually implemented,
it turns out that that medical treatment had a 9.5% (33/
349) mortality rate compared with 4.1% (17/419; P =
0.003) for surgery, an analysis that Newell says "would
have wildly exaggerated the apparent value of surgery."
Common sense, however, suggests that appearances are
not deceiving and patients and physicians should try as
hard as possible to implement surgery. Common sense
dictates that a patient is interested in surgery, not the effect
of being assigned to surgery, and that a patient has a right
to expect that if they comply, the physician would avoid
conditions where, as stated by Hollis [14] "most types of
deviations from protocol would continue to occur in rou-
tine practice." The idea that "Intention to treat analysis is
... most suitable for pragmatic trials of effectiveness rather
than for explanatory investigations of efficacy" assumes
again that practical considerations are the same every-
where and that any practitioner is locked into the same
abilities as the experimenter.
Geometric argument against ITT
What is actually accomplished in an ITT analysis? A die-
tary intervention (or drug trial) has, in the simplest case,
two outcomes, adherence and efficacy. A geometrical
argument would describe the results of the experiment as
a 2-dimensional outcome space where the length of a vec-
tor tells how every subject did but the separate coordinates
of outcome and efficacy would be reported. ITT represents
a projection of the vector onto one axis, in other words
collapses a two dimensional vector to a one-dimensional
vector, thereby losing part of the information.
Bias
The supposed value of ITT is that "an analysis that
excludes noncompliant patients is no longer randomized
and might cause serious bias" but "bias" is an emotionally
charged word and it is not clear what kind of bias is intro-
duced. In fact, the kind of misleading bias that is implied
in the term is what happens when you leave non-compli-
ers in the study. Consider that if it were known before the
experiment that some subjects, for whatever reason, reli-
Table 2: Survivors and deaths, 2 years after allocation to surgery or medical treatment in the CABS trial. Data as reported in 
reference [3]
Allocated to medicine Allocated to surgery
Received surgery Received medicine Received surgery Received medicine
Survived 2 years 48 296 354 20
Died 2 27 15 6
Total 50 323 369 26Nutrition & Metabolism 2009, 6:1 http://www.nutritionandmetabolism.com/content/6/1/1
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gious or psychological, would refuse to take the medica-
tion or would refuse to consume the designated diet,
would it not make sense to exclude them in the trial for
fear that the results would be biased. Finding out after the
fact that they were different from your intended study
population does not change anything; including  them
introduce s bias. Hollis [14] describes how this bias could
be avoided "by randomization after the necessary event,
but this is not always possible in practice." It is not clear
why not. It is in fact what is done by discarding non-com-
pliers, and what is done in any scientific experiment in
which the data rather than the design of the experiment
are paramount.
Appropriate Uses of Intention to Treat
The most salient characteristic of the epidemic of obesity
and diabetes, is that the increase in caloric intake is almost
entirely due to carbohydrates. Government databases
show that the absolute amount of dietary fat stayed
roughly the same, or actually decreased for men and only
slightly increased for women: per cent of dietary fat and
saturated fat, of course, went down [15,16]. This might
well be described as a vast thirty year experiment in which
subjects were advised to reduce dietary fat and increase
carbohydrate – the previous thirty years might be consid-
ered a control group. The null hypothesis is that being
assigned to a population advised to reduce dietary fat
would have no improvement or would make worse obes-
ity, heart disease and general health. These are true ITT
conditions: we do not know if the poor outcome was due
to the group that did not follow the protocol and that
those who did reduce fat actually got better but could not
overpower the statistics. Moreover, we do not know the
mechanism and it is said the obesity epidemic is due to
reduced exercise and larger portion sizes. It is possible that
carbohydrate intake leads one to consume larger portions
or that the soporific effect of high carbohydrate intake
leads to lethargy but an ITT analysis simply says that being
assigned to a low fat group correlates with obesity and dia-
betes and presumably incidence of heart disease (the data
are not unambiguous here but it would be surprising if the
incidence of heart disease went down in an increasingly
obese and diabetic population).
A similar analysis applies to the recent results of the
Women's Health Initiative (WHI) where, as described by
the authors "over a mean of 8.1 years, a dietary interven-
tion that reduced total fat intake and increased intakes of
vegetables, fruits, and grains did not significantly reduce
the risk of CHD, stroke, or CVD..." and only a limited
weight loss compared to controls [1]. An ITT analysis,
which is all that one can do since individual data was not
reported, says that the null hypothesis is correct: the inter-
vention as individuals were randomly assigned had little
effect. It is important to point out, however, that, in the
WHI, it is not just that the assignment to the intervention
had little effect. There was a change in the behavior of the
experimental group who did reduce the amount of fat
(although not to the target 20%) and did increase the
amount of fruits and vegetables, which is why the results
were generally considered disappointing. An ITT analysis
says that actually reducing fat does not have the expected
beneficial outcome. The question that readers would most
want answered is not "what is the effect of being assigned
to the diet?" or "what is the effect of trying to comply with
the diet" but rather, as stated by the authors, what is the
effect of "reduced total fat intake and increased intakes of
vegetables, fruits, and grains?"
Summary
The ITT approach has been advanced as a way to over-
come the difficulties faced by a per protocol analysis when
answering the question of efficacy. It avoids the problem
of differential drop out when the likelihood of a subject's
becoming non-adherent is related to treatment and out-
come. For example, if subjects who did not lose weight
during a diet study were to drop out, all diets would
appear to be equally effective. An ITT analysis would
include the weight changes from non-adherent subjects.
ITT analyses are typically reported in a way that implies
that they have the final say on efficacy; Newell, for exam-
ple [3] insists that "In any study of a health intervention,
it is essential to remember patients or clients who would
not or could not complete the planned intervention, and
include them appropriately in the analysis." (My italics).
An ITT approach, because it includes non-adherent sub-
jects, cannot give the definitive answer as to how treat-
ments compare in adherent subjects. The ITT approach
answers a different question, namely, what happens when
people are assigned to a particular treatment or what hap-
pens when a particular treatment is recommended. Again,
if authors choose to report that, they must make clear
what question is being asked.
The possibility that the questions of compliance and effi-
cacy are not independent – that, for example, a diet that
worked well might encourage dieters' compliance, while
reasonable in many cases, needs to be proved and cannot
be assumed at the experimenter's will. In some sense, the
name tells the story. All kinds of complicated experiments
are paved with good intentions, but it is the experiment
not the experimenter that counts.
Practical consequences and recommendations
The ITT approach has gained ascendancy in the world of
medical research and may actually be required by some
editors or granting agencies (see Supplemental Material).
Researchers may thus have no choice but to perform such
an analysis but it should not be done without awarenessNutrition & Metabolism 2009, 6:1 http://www.nutritionandmetabolism.com/content/6/1/1
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of what question is being asked, and whether it is, in fact,
the one that is most desirable. Analyses that separate
adherence and efficacy may, in fact, be more relevant. This
is especially true if we want to make health recommenda-
tions. Marantz [17] has stated the principle well: "Public
health, just like personal-encounter medicine, should be
guided by the dictum "first, do no harm." Sometimes, in
the absence of clear and convincing evidence of net bene-
fit, that will mean: do not issue dietary guidelines at all."
Whether vitamin E should be recommended is open to
further study but should not be dismissed on the basis of
a faulty analysis. Similarly, it may well be that the evi-
dence that carbohydrate-restricted diets are better than
other nutritional approaches is insufficient to warrant
blanket recommendation but that evidence should not be
compromised by an unjustifiable statistical principle.
Unless one assumes that compliance is an unalterable
character trait and that health professionals cannot effec-
tively encourage dieters at all, one might be concerned
about negative impact of people ignoring a diet or supple-
ment that might be effective. These problems are not a sta-
tistical niceties and have the potential for practical harm
and should be considered carefully.
Authors my choose to use both ITT and the performance
of compliers but, again, if ITT is used, it must be clearly
stated that it is taking assignment to a protocol as the
independent variable, that is, it is asking the question
"what is the effect of being assigned to a particular group?"
The ITT controversy
Advocates of ITT see its principles as established and may
dismiss a common sense approach as naïve. The issue is
not easily resolved; statistics does not truly derive from a
priori principles. Most statisticians would agree that the
discipline, in general, is a way of quantifying our intui-
tions. If this is not appreciated, and one does not go back
to the question to be asked, it is easy to develop a dog-
matic approach and insist on a particular statistic because
it has become standard. An anonymous reviewer of an
earlier version of this paper suggested that "the arguments
presented by the author may have applied, maybe, ten or
fifteen years ago." This criticism reminds one of Molière's
Doctor in Spite of Himself:
Sganarelle is disguised as a doctor and spouts medical
double-talk with phony Latin, Greek and Hebrew to
impress the client Geronte who is pretty dumb and
mostly falls for it but:
Geronte: ...there is only one thing that bothers me: the
location of the liver and the heart. It seemed to me that
you had them in the wrong place: the heart is on the
left side but the liver is on the right side.
Sgnarelle: Yes. That used to be true but we have
changed all that and medicine uses an entirely new
approach.
Geronte: I didn't know that and I beg your pardon for
my ignorance.
In the end, it is reasonable that scientific knowledge be
based on real observations. This has never before been
thought to include data that was not actually in the exper-
iment. I doubt that nous avons changé tout cela.
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